Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2007
02/08/2007US20070032519 Compounds modulating c-kit and c-fms activity and uses therefor
02/08/2007US20070032518 Compounds and methods of use
02/08/2007US20070032517 such as N-[3-acetyl-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-1-methyl-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl]acetamide, used as selective antagonists of cannabinoid-1 receptors, useful in the treatment, prevention and suppression of nervous system disorders
02/08/2007US20070032515 Anaplastic lymphoma kinase modulators and methods of use
02/08/2007US20070032503 Method of preparation of azaindole derivatives
02/08/2007US20070032485 cholesteryl ester transfer protein (CETP) anatgonists such as 2R,4S)-4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(morpholin-4-yl)pyrimidin-2-yl]}amino-2-ethyl-6-methoxy-3,4-dihydro-2H-[1,5]naphthyridine-1-carboxylic acid ethyl ester, having improved bioavailability
02/08/2007DE102005037115A1 Mehrfachchromophore Polychromophores
02/08/2007CA2617213A1 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
02/08/2007CA2617102A1 Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists
02/08/2007CA2616669A1 Squaric acid derivatives_ii
02/08/2007CA2616161A1 Diazepinoquinolines, synthesis thereof, and intermediates thereto
02/08/2007CA2614257A1 Inhibitors of checkpoint kinases
02/08/2007CA2614157A1 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents
02/07/2007EP1749829A1 JNK inhibitors
02/07/2007EP1749316A2 Perylene n-type semiconductors and related devices
02/07/2007EP1749008A1 Bicyclic heterocycles as hiv integrase inhibitors
02/07/2007EP1749006A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
02/07/2007EP1749005A1 Tetrahydro-imidazo ¬1,5-a| pyridin derivatives as aldosterone synthase inhibitors
02/07/2007EP1749004A1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents
02/07/2007EP1748989A2 Aryl sulfonamides
02/07/2007EP1748986A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
02/07/2007EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity
02/07/2007EP1315501B1 Alpha v integrin receptor antagonists
02/07/2007EP1242382B1 Tricyclic protein kinase inhibitors
02/07/2007CN1910183A Tetrahydrocarboline compounds as anticancer agents
02/07/2007CN1910182A Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
02/07/2007CN1910181A Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
02/07/2007CN1910156A Malononitrile compound as pesticide
02/07/2007CN1910155A Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis
02/07/2007CN1910141A Diamino alcohols and their use as renin inhibitors
02/07/2007CN1910135A Amino alcohol derivatives and their activity as renin inhibitors
02/07/2007CN1907982A New compounds useful for the treatment of obesity,type II diabetes and CNS disorders
02/07/2007CN1298718C Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application
02/07/2007CN1298717C Quinuclidine carbamate derivatives and their use as M3 antigonists
02/07/2007CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions
02/07/2007CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof
02/07/2007CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them
02/07/2007CN1298704C Isatine derivatives with neurotrophic activity
02/07/2007CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors
02/06/2007US7173133 cCs-rac-4-phenyl-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one; treating diseases related to activation of NMDA receptors via Glyt-1 inhibition
02/06/2007US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides
02/06/2007US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
02/06/2007US7173054 Respiratory syncytial virus replication inhibitors
02/06/2007US7173042 Quinoline inhibitors of cGMP phosphodiesterase
02/06/2007US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/06/2007US7173037 Compounds for trearment of cardiovascular disorders and hypotensive agents
02/06/2007US7173034 Drugs for treatment of viral diseases such as Respiratory syncytial virus
02/06/2007US7173031 Pyrrolotriazine kinase inhibitors
02/06/2007US7173029 Fused heteroaryl derivatives
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007US7173022 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides
02/01/2007WO2007013691A1 Spiro-cyclic compound
02/01/2007WO2007013601A1 Labeling dye for biomolecule, labeling kit, and method for detecting biomolecule
02/01/2007WO2007012650A1 Isotopically substituted proton pump inhibitors
02/01/2007WO2007012611A1 Naphthalene amidine imides
02/01/2007WO2006129120A3 Benzotriazepinone derivatives
02/01/2007WO2006108689A3 Process for preparing bicyclic compounds
02/01/2007WO2005063745A9 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
02/01/2007US20070027321 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
02/01/2007US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators
02/01/2007US20070027186 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
02/01/2007US20070027180 Process for preparing zolpidem
02/01/2007US20070027179 Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
02/01/2007US20070027178 Substituted tetrahydro-1H-pyrido[4,3-b]indoles as serotonin receptors agonists and antagonists
02/01/2007US20070027177 11-(3-fluorophenyl)-9-methoxy-3,4-dihydro-2H-pyrido[1,2-b]isoquinoline-1,6-dione, used as antiarrhythmia agents
02/01/2007US20070027174 Phenylalanine Enamide Derivatives
02/01/2007US20070027171 Cycloalkanepyrrolopyridines as dp receptor antagonists
02/01/2007US20070027158 High affinity small molecule C5a receptor modulators
02/01/2007US20070027149 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors
02/01/2007US20070027138 Derivatives and analogs of galanthamine
02/01/2007US20070027133 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
02/01/2007DE102005035916A1 Verfahren zur Herstellung von Bleichkatalysator-Granulaten A process for producing bleach catalyst granules
02/01/2007CA2617042A1 Spiro-cyclic compound
02/01/2007CA2615700A1 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
02/01/2007CA2615670A1 Isotopically substituted proton pump inhibitors
02/01/2007CA2608733A1 Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
01/2007
01/31/2007EP1748048A1 Imidazopyridine compound
01/31/2007EP1747779A1 Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands
01/31/2007EP1747222A1 Pyrimidine derivatives antagonists of vitronectin receptor
01/31/2007EP1747221A1 Fused ring nk1 antagonists
01/31/2007EP1747220A1 Substituted 1h-pyrrolo 3,2-b, 3,2-c, and 2,3-c¨pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
01/31/2007EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
01/31/2007EP1747208A1 Novel sustained-action bronchodilating agents for use in the treatment of respiratory diseases
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1746997A2 3-(4-heteroarylcyclohexylamino) czclopentanecarboxamides as modulators of chemokine receptors
01/31/2007EP1746994A2 Thienopyridinone compounds and methods of treatment
01/31/2007EP1585746B1 Naphthyridine derivatives and their use as fungicides
01/31/2007EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
01/31/2007CN1906200A Novel compounds
01/31/2007CN1906195A 2,4-dioxopyrimidine-based mesoionic pigments
01/31/2007CN1906194A Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
01/31/2007CN1906193A Oxime substituted imidazo ring compounds
01/31/2007CN1906192A Hydroxylamine substituted imidazo ring compounds
01/31/2007CN1906189A 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders
01/31/2007CN1906177A Process for the preparation of pyridopyrimidones
01/31/2007CN1906168A Methods and compositions for selectin inhibition
01/31/2007CN1906162A Hydroxy piperidine derivatives to treat gaucher disease
01/31/2007CN1906161A N-sulfonyldicarboximide containing tethering compounds
01/31/2007CN1905884A Pyrazole derivatives as inhibitors of receptor tyrosyne kinases